Huasen Pharmaceuticals: To pay back taxes of 7.1747 million yuan and late fees of 2.848 million yuan.

Huasen Pharmaceuticals announced that the company discovered in the tax compliance self-inspection that, due to differences in the tax treatment of convertible bond interest expenses, it needs to pay an additional 7.1747 million yuan in corporate income tax and 2.8448 million yuan in late fees. The company has now completed the payment of taxes and late fees. This issue will affect the net profit attributable to the shareholders of the listed company in 2025 by 10.0195 million yuan. The final data is subject to audit results.